新闻
2023-05-15
TILT Biotherapeutics Announces First Patient Dosed in Phase I Solid Tumors Trial Assessing Oncolytic Adenovirus TILT-123 in Combination with Checkpoint Inhibitor
免疫疗法临床1期临床2期
2023-05-15
大冢制药「泊那替尼片」国内报上市!
优先审批申请上市
2023-05-15
又一国产新药获“FDA孤儿药”认定!
孤儿药上市批准
2023-05-15
信达生物KRAS G12C抑制剂IBI351被国家药品监督管理局纳入突破性治疗药物品种,治疗晚期结直肠癌患者
突破性疗法ASCO会议临床结果申请上市
2023-05-12
Nkarta to Present NKX019 Phase 1 Dose Escalation Data at European Hematology Association 2023 Congress and 17th International Conference on Malignant Lymphoma
免疫疗法细胞疗法临床1期
2023-05-12
Editas Medicine to Present Clinical Data from the RUBY Trial of EDIT-301 for the Treatment of Severe Sickle Cell Disease at the EHA 2023 Congress
临床研究免疫疗法细胞疗法基因疗法
2023-05-12
Mustang Bio Announces Upcoming Presentations of Clinical Data from Phase 1/2 Trial of MB-106, a CD20-Targeted Autologous CAR T Cell Therapy
细胞疗法免疫疗法临床研究
2023-05-12
FDA批准首款阿尔茨海默症激越药物:Brexpiprazole
抗体药物偶联物上市批准引进/卖出
2023-05-12
贝达药业:伏罗尼布玻璃体注射剂申报临床
临床3期申请上市抗体药物偶联物
2023-05-12
全球新药进展早知道
更多数据请注册后访问新药情报库PC端查看
synapse.zhihuiya.com
复制网址